265147801647715526514780746747966286956628695662869563003680001853021--12-312022Q3false00006628695662869500000026514780662869516477155662869526514780662869574674796300368000.060.440.000.740.060.440.000.740.33P2DP10D0.060.060.440.4474674790.000.000.740.740.33000000001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-240001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-240001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-240001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-240001853021us-gaap:FairValueInputsLevel3Membermtal:MeasurementInputUnderlyingWarrantValueMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-240001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-060001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-060001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-060001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-060001853021us-gaap:FairValueInputsLevel3Membermtal:MeasurementInputUnderlyingWarrantValueMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-060001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMember2021-12-310001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2021-12-310001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMember2021-12-310001853021us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2021-12-310001853021mtal:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001853021mtal:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001853021mtal:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001853021mtal:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001853021mtal:CommonClassaSubjectToRedemptionMember2022-09-300001853021mtal:CommonClassaSubjectToRedemptionMember2021-12-310001853021us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001853021mtal:SponsorMemberus-gaap:CommonClassBMember2022-01-012022-09-300001853021us-gaap:AdditionalPaidInCapitalMember2021-03-112021-03-310001853021mtal:SponsorMemberus-gaap:CommonClassBMember2021-09-162021-09-160001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-07-012021-09-300001853021mtal:FounderMember2021-07-012021-09-300001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-112021-03-310001853021us-gaap:CommonClassBMember2021-03-012021-03-310001853021us-gaap:RetainedEarningsMember2022-09-300001853021us-gaap:RetainedEarningsMember2022-06-300001853021us-gaap:AdditionalPaidInCapitalMember2022-06-3000018530212022-06-300001853021us-gaap:RetainedEarningsMember2022-03-3100018530212022-03-310001853021us-gaap:RetainedEarningsMember2021-12-310001853021us-gaap:AdditionalPaidInCapitalMember2021-12-310001853021us-gaap:RetainedEarningsMember2021-09-300001853021us-gaap:RetainedEarningsMember2021-06-300001853021us-gaap:AdditionalPaidInCapitalMember2021-06-3000018530212021-06-300001853021us-gaap:RetainedEarningsMember2021-03-310001853021us-gaap:AdditionalPaidInCapitalMember2021-03-3100018530212021-03-310001853021us-gaap:RetainedEarningsMember2021-03-100001853021us-gaap:AdditionalPaidInCapitalMember2021-03-100001853021us-gaap:IPOMember2021-08-020001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-09-300001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-06-300001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-03-310001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001853021us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-09-300001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-06-300001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-310001853021us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-100001853021us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-100001853021us-gaap:PrivatePlacementMember2021-09-032021-09-030001853021mtal:PromissoryNoteWithRelatedPartyMember2021-12-310001853021mtal:WorkingCapitalLoansWarrantMember2021-12-310001853021us-gaap:RetainedEarningsMember2022-07-012022-09-300001853021us-gaap:RetainedEarningsMember2022-04-012022-06-300001853021us-gaap:RetainedEarningsMember2022-01-012022-03-3100018530212022-01-012022-03-310001853021us-gaap:RetainedEarningsMember2021-04-012021-06-3000018530212021-04-012021-06-300001853021us-gaap:RetainedEarningsMember2021-03-112021-03-3100018530212021-03-112021-03-310001853021us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001853021us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001853021mtal:AnchorInvestorsMemberus-gaap:IPOMember2022-09-300001853021mtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-050001853021mtal:ConvertiblePromissoryNoteWithRelatedPartyMembermtal:SponsorMember2022-07-012022-09-300001853021mtal:ConvertiblePromissoryNoteWithRelatedPartyMembermtal:SponsorMember2022-01-012022-09-3000018530212021-03-112022-09-300001853021mtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-01-012022-09-300001853021us-gaap:CommonClassBMember2022-07-012022-09-300001853021us-gaap:CommonClassAMember2022-07-012022-09-300001853021us-gaap:CommonClassBMember2022-01-012022-09-300001853021us-gaap:CommonClassBMember2021-07-012021-09-300001853021us-gaap:CommonClassAMember2021-07-012021-09-300001853021us-gaap:CommonClassBMember2021-03-112021-09-300001853021us-gaap:CommonClassAMember2021-03-112021-09-300001853021mtal:PrivatePlacementWarrantsMembermtal:SponsorMember2022-09-300001853021mtal:SponsorMemberus-gaap:CommonClassBMember2021-12-310001853021mtal:SponsorMemberus-gaap:CommonClassBMember2022-09-300001853021us-gaap:CommonClassAMember2022-09-300001853021us-gaap:CommonClassAMember2022-06-300001853021us-gaap:CommonClassBMember2021-12-310001853021us-gaap:CommonClassAMember2021-12-310001853021us-gaap:CommonClassBMember2021-03-310001853021mtal:PublicWarrantsMember2022-09-300001853021mtal:PrivatePlacementWarrantsMembermtal:SponsorMember2022-05-240001853021mtal:PrivatePlacementWarrantsMembermtal:SponsorMember2022-05-060001853021us-gaap:CommonClassAMember2021-09-030001853021us-gaap:CommonClassAMemberus-gaap:IPOMember2021-08-020001853021us-gaap:CommonClassAMember2021-08-0200018530212021-09-3000018530212021-03-100001853021mtal:ShareSaleAgreementMember2022-03-170001853021us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001853021us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-3100018530212022-05-242022-05-240001853021mtal:AdvisoryServiceAgreementMember2022-09-3000018530212021-09-032021-09-0300018530212021-08-022021-08-020001853021us-gaap:OverAllotmentOptionMember2021-08-020001853021us-gaap:PrivatePlacementMember2022-01-012022-09-300001853021us-gaap:WarrantMemberus-gaap:IPOMember2022-09-300001853021mtal:PrivatePlacementWarrantsMemberus-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2022-01-012022-09-3000018530212021-01-012021-12-310001853021mtal:SponsorMember2022-09-300001853021mtal:AnchorInvestorsMember2021-03-110001853021mtal:AnchorInvestorsMemberus-gaap:IPOMember2021-08-020001853021us-gaap:OverAllotmentOptionMember2021-09-032021-09-0300018530212021-03-112021-12-310001853021mtal:CoAdvisorMembermtal:AgreementThreeForInvestmentBankingServicesMember2022-03-162022-03-160001853021mtal:AgreementOneForInvestmentBankingServicesMember2022-01-192022-01-1900018530212021-09-030001853021us-gaap:OverAllotmentOptionMember2022-01-012022-09-300001853021mtal:AnchorInvestorsMember2022-01-012022-09-300001853021mtal:AnchorInvestorsMemberus-gaap:IPOMember2021-08-022021-08-020001853021us-gaap:IPOMember2021-08-022021-08-020001853021mtal:PrivatePlacementWarrantsMembermtal:SponsorMember2022-05-242022-05-240001853021mtal:PublicWarrantsMemberus-gaap:OverAllotmentOptionMember2022-01-012022-09-300001853021mtal:PrivatePlacementWarrantsMemberus-gaap:OverAllotmentOptionMember2022-01-012022-09-300001853021mtal:PrivatePlacementWarrantsMemberus-gaap:IPOMember2022-01-012022-09-300001853021us-gaap:CommonClassBMemberus-gaap:OverAllotmentOptionMember2021-03-310001853021mtal:SponsorMemberus-gaap:CommonClassBMember2021-03-310001853021mtal:AnchorInvestorsMember2022-09-300001853021us-gaap:CommonClassAMemberus-gaap:IPOMember2021-08-022021-08-020001853021us-gaap:CommonClassBMemberus-gaap:OverAllotmentOptionMember2021-09-032021-09-030001853021mtal:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-08-022021-08-0200018530212022-05-060001853021mtal:SponsorMemberus-gaap:SubsequentEventMember2022-10-250001853021mtal:PromissoryNoteWithRelatedPartyMember2022-09-300001853021us-gaap:ConvertibleDebtMember2022-04-130001853021mtal:AgreementTwoForInvestmentBankingServicesMember2022-03-162022-03-160001853021mtal:AgreementThreeForInvestmentBankingServicesMember2022-03-162022-03-160001853021mtal:AdvisoryServiceAgreementMember2022-01-012022-09-300001853021us-gaap:WarrantMember2022-01-012022-09-300001853021mtal:ConvertiblePromissoryNoteWithRelatedPartyMember2022-05-062022-05-240001853021us-gaap:IPOMember2022-09-300001853021us-gaap:OverAllotmentOptionMember2021-09-030001853021mtal:TaxPlanningServicesAgreementMember2022-09-300001853021mtal:TaxPlanningServicesAgreementMember2021-12-310001853021mtal:PrivatePlacementWarrantsMembermtal:ConvertiblePromissoryNoteWithRelatedPartyMembermtal:SponsorMember2022-05-2400018530212021-03-112021-03-110001853021us-gaap:RetainedEarningsMember2021-07-012021-09-300001853021us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-07-012021-09-300001853021us-gaap:CommonClassBMember2022-09-300001853021mtal:WorkingCapitalLoansWarrantMember2022-09-300001853021mtal:ConvertiblePromissoryNoteWithRelatedPartyMembermtal:SponsorMember2022-05-060001853021us-gaap:PrivatePlacementMember2021-09-030001853021mtal:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-08-020001853021mtal:PrivatePlacementWarrantsMemberus-gaap:CommonClassAMember2021-08-020001853021mtal:PrivatePlacementWarrantsMember2021-09-032021-09-030001853021mtal:PrivatePlacementWarrantsMember2021-08-022021-08-020001853021mtal:RedemptionOfWarrantPricePerShareEqualsOrExceeds18.00Membermtal:PublicWarrantsMember2022-01-012022-09-300001853021mtal:RedemptionOfWarrantPricePerShareEqualsOrExceeds10.00Membermtal:PublicWarrantsMember2022-01-012022-09-300001853021mtal:RedemptionOfWarrantPricePerShareEqualsOrExceeds18.00Membermtal:PublicWarrantsMember2022-09-300001853021mtal:RedemptionOfWarrantPricePerShareEqualsOrExceeds10.00Membermtal:PublicWarrantsMember2022-09-300001853021mtal:PublicWarrantsMember2022-01-012022-09-300001853021us-gaap:OverAllotmentOptionMember2021-09-162021-09-1600018530212021-09-162021-09-160001853021mtal:ShareSaleAgreementMember2022-03-172022-03-1700018530212022-07-012022-09-300001853021mtal:SponsorMemberus-gaap:CommonClassBMember2021-03-012021-03-3100018530212021-03-112021-09-300001853021us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-3000018530212021-07-012021-09-300001853021us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000018530212022-04-012022-06-3000018530212022-09-3000018530212021-12-310001853021mtal:LegalServicesAgreementMember2022-01-012022-09-300001853021mtal:LegalServicesAgreementMember2021-01-012021-12-310001853021us-gaap:CommonClassAMember2022-01-012022-09-300001853021mtal:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember2022-01-012022-09-300001853021mtal:UnitEachConsistingOfOneClassCommonStockAndOneThirdRedeemableWarrantMember2022-01-012022-09-300001853021us-gaap:CommonClassBMember2022-11-140001853021us-gaap:CommonClassAMember2022-11-1400018530212022-01-012022-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puremtal:Dmtal:Votemtal:itemmtal:agreementmtal:Y

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to

METALS ACQUISITION CORP

(Exact name of registrant as specified in its charter)

Cayman Islands

    

001-40685

    

98-1589041

(State or other jurisdiction of

(Commission

(I.R.S. Employer

incorporation or organization)

File Number)

Identification Number)

Century House, Ground Floor

Cricket Square, P.O. Box 2238

Grand Cayman KY1-1107, Cayman Islands

(Address of principal executive offices)

(817) 698-9901

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Not applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

    

Trading Symbol(s)

    

Name of each Exchange on which Registered

Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant

 

MTAL.U

 

New York Stock Exchange

Class A ordinary shares, included as part of the units

 

MTAL

 

New York Stock Exchange

Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

 

MTAL.WS

 

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No 

As of November 14, 2022, 26,514,780 Class A ordinary shares, par value $0.0001 per share, and 6,628,695 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding, respectively.

Table of Contents

METALS ACQUISITION CORP

Form 10 Q

For the Quarter Ended September 30, 2022

Table of Contents

Page

PART I. FINANCIAL INFORMATION

Item 1.

Consolidated Financial Statements

Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021

1

Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2022 and 2021, Nine Months Ended September 30, 2022 and for the Period from March 11, 2021 (Inception) through September 30, 2021

2

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three Months Ended September 30, 2022 and 2021, Nine Months Ended September 30, 2022 and for the Period from March 11, 2021 (Inception) through September 30, 2021

3

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022, and for the Period from March 11, 2021 (Inception) through September 30, 2021

4

Notes to Unaudited Condensed Consolidated Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

30

Item 4.

Controls and Procedures

30

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

31

Item 1A.

Risk Factors.

31

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 3.

Defaults Upon Senior Securities

31

Item 4.

Mine Safety Disclosures

31

Item 5.

Other Information

31

Item 6.

Exhibits

32

i

Table of Contents

METALS ACQUISITION CORP

CONDENSED CONSOLIDATED BALANCE SHEETS

September 30, 2022

December 31, 2021

    

(Unaudited)

    

Assets

Current assets:

Cash

$

244,247

$

954,974

Prepaid expenses

 

307,296

 

340,271

Total current assets

551,543

1,295,245

Long-term prepaid expenses

 

 

186,988

Marketable securities held in Trust Account

266,693,693

265,155,619

Deferred financing costs

425,858

Total Assets

$

267,671,094

$

266,637,852

Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit

 

  

 

  

Accrued expenses and accounts payable

$

671,676

$

86,862

Due to related party

65,427

Total current liabilities

 

737,103

 

86,862

Deferred liabilities

2,952,473

517,612

Warrant liability

5,605,114

8,440,008

Deferred underwriting discount

9,280,173

9,280,173

Total Liabilities

18,574,863

18,324,655

 

  

 

  

Commitments and Contingencies (Note 7)

 

  

 

  

Class A ordinary shares subject to possible redemption, 26,514,780 shares at redemption value of $10.06 and $10.00 per share as of September 30, 2022 and December 31, 2021, respectively

266,693,693

265,147,800

 

  

 

  

Shareholders' Deficit:

 

  

 

  

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding

 

 

Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued and outstanding (excluding 26,514,780 shares subject to possible redemption)

 

 

Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 6,628,695 shares issued and outstanding

 

663

 

663

Additional paid-in capital

 

 

Accumulated deficit

 

(17,598,125)

 

(16,835,266)

Total Shareholders’ Deficit

 

(17,597,462)

 

(16,834,603)

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit

$

267,671,094

$

266,637,852

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1

Table of Contents

METALS ACQUISITION CORP

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the period from

March 11,

For the Three Months Ended

For the Nine months

2021 (Inception)

September 30,

Ended September 30,

Through September 30,

    

2022

    

2021

    

2022

    

2021

Operating and formation costs

$

1,761,004

$

90,299

$

4,785,165

$

96,547

Loss from operations

(1,761,004)

(90,299)

(4,785,165)

(96,547)

Other income (expense):

Change in fair value of warrants

2,588,610

13,400,065

3,314,893

13,400,065

Offering expenses related to warrant issuance

(2,024,525)

(2,024,525)

Excess value of Private Placement Warrants

(1,066,666)

(1,066,666)

Change in fair value conversion option

7,200

Change in foreign exchange

(782)

(782)

Trust interest income

1,173,324

2,491

1,538,074

2,491

Amortization of discount on convertible promissory note

(8,000)

Bank fee

(1,477)

(738)

(3,986)

(1,413)

Total Other income, net

3,759,675

10,310,627

4,847,399

10,309,952

Net income

$

1,998,671

$

10,220,328

$

62,234

$

10,213,405

Basic and diluted weighted average Class A shares outstanding, ordinary shares subject to possible redemption

26,514,780

16,477,155

26,514,780

7,467,479

Basic and diluted net income per share, Class A ordinary shares

$

0.06

$

0.44

$

0.00

$

0.74

Basic and diluted weighted average Class B ordinary shares outstanding

6,628,695

6,628,695

6,628,695

6,300,368

Basic and diluted net income per share, Class B ordinary shares

$

0.06

$

0.44

$

0.00

$

0.74

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

Table of Contents

METALS ACQUISITION CORP

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’
DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

Class A

Class B

Additional

Total

Ordinary Shares

Ordinary Shares

Paid-In

Accumulated

Shareholders'

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance as of January 1, 2022

$

6,628,695

$

663

$

$

(16,835,266)

$

(16,834,603)

Remeasurement of Class A ordinary shares subject to possible redemption

(25,233)

(25,233)

Net loss

(5,848,813)

(5,848,813)

Balance as of March 31, 2022

6,628,695

663

(22,709,312)

(22,708,649)

Contribution of conversion price in excess of fair value of warrants

720,800

720,800

Remeasurement of Class A ordinary shares subject to possible redemption

(347,335)

(347,335)

Net income

3,912,376

3,912,376

Balance as of June 30, 2022

6,628,695

663

373,465

(18,796,936)

(18,422,808)

Remeasurement of Class A ordinary shares subject to possible redemption

(373,465)

(799,860)

(1,173,325)

Net income

1,998,671

1,998,671

Balance as of September 30, 2022

$

6,628,695

$

663

$

$

(17,598,125)

$

(17,597,462)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND FOR THE PERIOD FROM MARCH 11, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021

Class A

Class B

Additional

Total

Ordinary Shares

Ordinary Shares

Paid-In

Accumulated

Shareholders'

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Equity (Deficit)

Balance as of March 11, 2021 (Inception)

$

$

$

$

$

Class B ordinary shares issued to Sponsor

7,187,500

719

24,281

25,000

Net loss

 

 

 

 

(6,894)

 

(6,894)

Balance as of March 31, 2021

 

7,187,500

719

24,281

(6,894)

18,106

Net loss

(29)

(29)

Balance as of June 30, 2021

7,187,500

719

24,281

(6,923)

$

18,077

Sale of 26,514,780 Units on August 2, 2021, and September 3, 2021, through public offering, net of offering costs

26,514,780

2,651

265,145,149

265,147,800

Sale of 5,535,304 Private Placement Warrants on August 2, 2021, and September 3, 2021

8,302,958

8,302,958

Forfeiture of 558,805 founder shares

(558,805)

(56)

56

Initial classification of warrant liability

(23,462,852)

(23,462,852)

Excess value of Private Placement Warrants

1,066,666

1,066,666

Underwriting fee

(5,302,956)

(5,302,956)

Deferred underwriting fee

(9,280,173)

(9,280,173)

Fair value of Class B shares sold to Anchor Investors

(11,107,653)

(11,107,653)

Capital contribution for sale of Class B shares to Anchor Investors

11,107,653

11,107,653

Offering costs charged to the shareholders’ equity

(1,022,789)

(1,022,789)

Offering costs allocated to Public Warrants

2,024,525

2,024,525

Net income

10,220,328

10,220,328

Change in Class A ordinary shares subject to possible redemption

(26,514,780)

(2,651)

(237,494,865)

(27,650,284)

(265,147,800)

Balance as of September 30, 2021

$

6,628,695

$

663

$

$

(17,436,879)

$

(17,436,216)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Table of Contents

METALS ACQUISITION CORP

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    

For the period from

For the Nine Months

    

March 11, 2021

Ended

(Inception) to

    

September 30, 2022

    

September 30, 2021

Cash flows from Operating Activities:

Net income

$

62,234

$

10,213,405

Adjustments to reconcile net income to net cash used in operating activities:

 

 

Offering expenses related to warrant issuance

2,024,525

Excess value of Private Placement Warrants

1,066,666

Interest earned on marketable securities held in Trust Account

(1,538,074)

(2,491)

Change in fair value of warrants

(3,314,893)

(13,400,065)

Change in foreign exchange rates

782

Change in fair value of conversion option

(7,200)

Amortization of discount on convertible promissory note

8,000

Changes in operating assets and liabilities:

Prepaid expenses

 

219,963

 

(615,932)

Accrued expenses and accounts payable

158,173

Due to related party

65,427

Deferred liabilities

2,434,861

Net cash used in operating activities

(1,910,727)

 

(713,892)

Cash Flows from Investing Activities:

Investment held in Trust Account

(265,147,800)

Net cash used in investing activities

(265,147,800)

 

  

 

  

Cash flows from Financing Activities:

 

  

 

  

Proceeds from convertible promissory note – related party

 

1,200,000

 

Proceeds from Initial Public Offering, net of underwriters' fees

259,844,844

Proceeds from private placement

8,302,958

Advances from related parties

150,000

Payments to related parties

(150,000)

Payments of offering costs

(992,316)

Net cash provided by financing activities

 

1,200,000

 

267,155,486

 

  

 

  

Net change in cash

 

(710,727)

 

1,293,794

Cash, beginning of the period

 

954,974

 

Cash, end of the period

$

244,247

$

1,293,794

 

 

Supplemental disclosure of noncash investing and financing activities:

 

 

Remeasurement of Class A ordinary shares subject to possible redemption

$

1,545,893

$

Deferred financing costs included in accrued expenses

$

426,641

$

Deferred underwriting commissions charged to additional paid in capital

$

$

9,280,173

Deferred offering costs paid by Sponsor in promissory note

$

$

Initial value of Class A ordinary shares subject to possible redemption

$

$

265,147,800

Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares

$

$

18,106

Initial classification of warrant liability

$

$

23,462,850

Private warrants issued upon conversion of related party promissory note

$

480,000

$

Capital contributed upon settlement of related party note

$

720,800

$

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Table of Contents

METALS ACQUISITION CORP

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 - Organization and Business Operations and Going Concern and Management’s Plan

Metals Acquisition Corp (together with its consolidated subsidiaries, except as the context otherwise requires, the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on March 11, 2021.The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). On March 4, 2022, a wholly owned subsidiary, Metals Acquisition Corp. (Australia) Pty Ltd (“MAC-Sub”) was incorporated under the Australian Corporations Act 2001 and registered in New South Wales for the purposes of an initial Business Acquisition.

As of September 30, 2022, the Company had not commenced any operations. All activity for the period from March 11, 2021 (inception) through September 30, 2022, relates to the Company’s formation, operating costs, and the initial public offering (the “IPO”), described below and activities related to seeking an acquisition target. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on investments in the trust account derived from the IPO. The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is Green Mountain Metals LLC, a Cayman Islands limited liability company (the “Sponsor”).

The registration statement for the Company’s IPO was declared effective on July 28, 2021 (the “Effective Date”). On August 2, 2021, the Company consummated its IPO of 25,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant of the Company (“Warrant”), each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $250,000,000, which is discussed in Note 3.

Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 5,333,333 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8,000,000. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of such warrants) are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO.

The underwriter had a 45-day option from the date of the Company’s IPO (August 2, 2021) to purchase up to an additional 3,750,000 Units to cover over-allotments, if any. On September 3, 2021, the Underwriter partially exercised the over-allotment option to purchase an additional 1,514,780 Units (the “Over-Allotment Units”) generating aggregate gross proceeds of $15,147,800 and incurring $302,956 in cash underwriting fees (see Notes 3 and 8) and $530,173 in deferred underwriting fees.

Simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the private placement with the Sponsor for an aggregate of 201,971 warrants to purchase Class A Ordinary Shares for $1.50 per warrant in a private placement with each whole warrant entitling the holder thereof to purchase one Class A Ordinary Share at $11.50 per share, subject to adjustment (the “Additional Private Placement Warrants”), generating total proceeds of $302,956 (the “Private Placement Proceeds” and, together with the Option Unit Proceeds, the “Proceeds”) (see Note 5).

On September 16, 2021, the remaining amounts under the over-allotment option expired unused and 558,805 Class B ordinary shares were forfeited by the Sponsor to the Company for no consideration.

The Additional Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of such warrants) are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO.

5

Table of Contents

Certain qualified institutional buyers or institutional accredited investors who are unaffiliated with the management team (“Anchor Investors”) purchased a total of 19,575,000 Units or 78.3% of the outstanding Units following the IPO (assuming no exercise of the over-allotment option). After the exercise of the Underwriter’s over-allotment option, the percentage purchased by Anchor Investors has decreased from 78.3% to 73.8%.

In addition, the Sponsor sold membership interests representing an aggregate of 1,272,500 founder shares to all Anchor Investors combined.

The Company estimated the aggregate fair value of these founder shares attributable to Anchor Investors via their purchase of the membership interest to be $11,107,653, or $8.73 per share. The founder shares purchased by the Anchor Investors represent a capital contribution by the Sponsor for the benefit of the Company and are recorded as offering costs and reflected as a reduction in the proceeds from the offering and offering expenses in accordance with ASC 470 and Staff Accounting Bulletin Topic 5A.

As the IPO included two instruments, Class A ordinary shares and warrants, and as the warrants are classified as a financial liability, it was necessary to allocate the gross proceeds between Class A ordinary shares and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A ordinary shares and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was then allocated to Class A ordinary shares. The percentage derived from this allocation was then used to allocate deferred offering costs between Class A ordinary shares and warrants. Issuance costs of $1,984,130 were allocated to the warrants and charged to the Company’s current period statement of operations.

The purchase of 78.3% in aggregate of the Units sold in the IPO, or 19,575,000 Units and the sales of membership interest by the Sponsor are hereby referred to as the “Anchor Investment.”

Transaction costs of the IPO amounted to $26,713,571 consisting of $5,302,956 of underwriting discounts, $9,280,173 of deferred underwriting discounts, fair value in the Anchor Investor shares of $11,107,653, and $1,022,789 of other offering costs. Of the transaction costs, $1,984,130 is included in other expenses and $24,729,441 is included in temporary equity.

A total of $265,147,800 was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee, upon closing of the IPO and the underwriter partially exercising its over-allotment option.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the Private Placement Warrants, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting commissions).

The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts previously disbursed to management for working capital purposes, if permitted, and excluding the amount of deferred underwriting discounts and commissions held in trust) at the time of signing an agreement to enter a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for so that the Company is not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

6

Table of Contents

The net proceeds from the initial public offering are held in a trust account and are invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association, as discussed below and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to the public shareholders, until the earliest of (a) the completion of the initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to the limitations described herein, (b) the redemption of any public shares properly tendered in connection with a (A) shareholder vote to amend the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 24 months from the closing of the IPO, or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares or pre-initial Business Combination activity, and (c) the redemption of the public shares if the Company has not consummated the initial Business Combination within 24 months from the closing of the IPO. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within 24 months from the closing of the IPO, with respect to such Class A ordinary shares so redeemed.

The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirements. The public shareholders are entitled to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein.

The ordinary shares subject to redemption are recorded at redemption value and have been classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company will have only 24 months from the closing of the IPO (the “Combination Period”) to complete the initial Business Combination. If the Company has not completed the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

7

Table of Contents

The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold, (ii) to waive their redemption rights with respect to any founder shares and any public shares purchased during or after the IPO in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period, or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any founder shares they hold if the Company fails to consummate the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period).

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay its tax obligations, provided that such liability will not apply to any claims by a third party or prospective partner business who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be liable for such third-party claims. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Accordingly, the Sponsor may not be able to satisfy those obligations.

On March 17, 2022, the Company and Glencore Operations Australia Pty Limited (“Glencore”) entered into a Share Sale Agreement (the “SSA”).

Under the terms of the SSA, the Company will acquire from Glencore 100% of the issued share capital of Cobar Management Pty. Limited (“CMPL”). CMPL owns and operates the Cornish, Scottish and Australian mine (the “CSA Mine”) in Cobar, New South Wales, Australia.

In consideration for the acquisition of CMPL, the Company will: (a) pay US$1,050,000,000 to Glencore (subject to a customary closing accounts adjustments to reflect the working capital, net debt and tax liabilities of CMPL at the time of closing under the SSA (the “Closing”)), (b) issue US$50,000,000 (5,000,000 shares) worth of MAC Class A ordinary shares, $0.0001 par value (the “Common Stock”) to Glencore, and (c) enter into a net smelter royalty pursuant to which after the Closing, CMPL will pay to Glencore a royalty of 1.5% of all net smelter copper concentrate produced from the mining tenure held by CMPL at the time of the Closing.

The business combination has been approved by the boards of directors of the Company and Glencore.

Going Concern and Management’s Plan

The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company’s business plan is dependent on the completion of a Business Combination and the Company’s cash and working capital as of September 30, 2022 are not sufficient to complete its planned activities. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

8

Table of Contents

As of September 30, 2022, the Company had $244,247 of cash and a working capital deficit of $120,133, which are not sufficient to complete its planned activities. On April 13, 2022, the Company issued an unsecured promissory note (the “Sponsor Convertible Note”) to the Sponsor pursuant to which the Company could borrow up to $1,200,000 from the Sponsor for working capital needs, including transaction costs reasonably related to the consummation of the Proposed Business Combination (Refer to Note 5). On May 6, 2022, the Company borrowed $1,200,000 under the Sponsor Convertible Note. On May 24, 2022, the Sponsor exercised its option to convert the issued and outstanding loan amount of $1,200,000 under the Sponsor Convertible Note resulting in the issuance of 800,000 private placement warrants to the Sponsor, fully satisfying the Company’s obligation under the Sponsor Convertible Note.

While the Company believes it has sufficient access to additional sources of capital, if necessary, there is no current commitment on the part of any financing source to provide additional capital and no assurances can be provided that such additional capital will ultimately be available. In addition, management has determined that if the Company is unable to complete a Business Combination by August 2, 2023, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution as well as the Company’s anticipated capital requirements raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed consolidated financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate the Proposed Business Combination will be successful or successful within the Combination Period.

Risks and Uncertainties

Results of operations and the Company’s ability to complete the Proposed Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

Liquidity and Capital Resources

As of September 30, 2022, the Company had $244,247 of cash and working capital deficit of $120,133.

To finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with Working Capital Loans, as defined below (see Note 5). As of September 30, 2022, there were no amounts outstanding under any Working Capital Loans.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as filed with the SEC on March 31, 2022. The interim results for the three and nine months ended September 30, 2022, are not necessarily indicative of the results to be expected for the year ending December 31, 2022, or for any future interim periods.

9

Table of Contents

The condensed consolidated financial statements include the accounts of a wholly-owned subsidiary Metals Acquisition Corp. (Australia) Pty Ltd (“MAC-Sub”), a private company incorporated in Australia. MAC-Sub is currently dormant.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. There were no intercompany transactions for the period ended September 30, 2022.

Reclassifications

Certain reclassifications have been made to the historical financial statements to conform to the current year’s presentation. Such reclassifications have no effect on net income (loss) as previously reported.

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”). The Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and qualifying for exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but that any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of these unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.

10

Table of Contents

Cash and Cash Equivalents

The Company had $244,247 and $954,974 of cash as of September 30, 2022 and December 31, 2021. The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.

Investments Held in Trust Account

At September 30, 2022 and December 31, 2021, funds held in the Trust Account included $266,693,693 and $265,155,619 of investments held in a money market fund characterized as Level 1 investments within the fair value hierarchy under ASC 820 (as defined below).

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on this account.

Promissory Note - Related Party

As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the promissory note. During the period from March 11, 2021 (inception) through September 30, 2022, the Company borrowed $167,251 under the promissory note. The Company fully repaid the outstanding amount at the closing of the IPO on August 2, 2021.

Advances from Related Parties

As of September 30, 2022 and December 31, 2021, the Company had no advances from related parties. During the period from March 11, 2021 (inception) through December 31, 2021, the Company had advances from related parties of $150,000 and the amount was fully repaid at close of the IPO. These advances were non-interest bearing and due on demand. There were no advances from related parties from January 1, 2022 through to September 30, 2022.

Convertible Debt

The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments.

The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually

11

Table of Contents

resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense.

Debt Financing Costs

The Company complies with the requirements of ASC 835-30-45-1A with respect to debt financing costs. Debt financing costs consist principally of legal and professional fees incurred through the balance sheet date that are directly related to the procurement of debt. Debt financing costs related to existing debt are capitalized and reported in the balance sheet as a direct deduction to the related debt and are amortized to interest expense over the term of the debt at the effective interest rate. Debt financing costs incurred prior to the closing of the related debt instrument are capitalized and reported in the balance sheet as a long-term deferred asset until the closing of the related debt instrument at which time the accumulated debt financing costs are capitalized to the debt instrument as previously discussed. As of September 30, 2022 and December 31, 2021, $425,858 and $0, respectively, were capitalized and are included in deferred financing costs on the condensed consolidated balance sheets.

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged to shareholders’ deficit or the consolidated statement of operations based on the relative value of the Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, as of December 31, 2021, offering costs totaling $26,713,571 (consisting of $5,302,956 of underwriting fees, $9,280,173 of deferred underwriting fees, $11,107,653 of fair value of founder shares sold to Anchor Investors, and $1,022,789 of other offering costs) were recognized. Of the $26,713,571 offering costs $1,984,130 were allocated to the Public and Private Warrants and included in other expenses for the period and $24,729,441 included in temporary equity.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” The Company’s derivative instruments are recorded at fair value as of the IPO (August 2, 2021) and re-valued at each reporting date, with changes in the fair value reported in the consolidated statement of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are derivative instruments. As the warrants meet the definition of a derivative, the warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, “Fair Value Measurement,” with changes in fair value recognized in the consolidated statement of operations in the period of change.

Warrant Instruments

The Company accounts for the 13,666,666 warrants issued in connection with the IPO and Private Placement and the additional 504,927 public warrants and 201,971 private placement warrants associated with the exercise of the over-allotment, in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” under which the warrants do not meet the criteria for equity treatment and must, thereby, be recorded as a liability. Accordingly, the Company classifies the warrant instrument as a liability at fair value and adjusts the instrument to fair value at each reporting period. This liability will be re-measured at each balance sheet date until the warrants are exercised or expire, and any change in fair value will be recognized in the Company’s consolidated statements of operations. The fair value of warrants will be estimated using observable market inputs. The valuation model utilizes inputs and other

12

Table of Contents

assumptions and may not be reflective of the price at which they can be settled. Such warrant classification is also subject to re-evaluation at each reporting period.

Fair Value Measurements

Fair value is defined as the price that would be received for the sale of an asset that would be paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholder’s deficit. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s consolidated balance sheet.

All of the Class A ordinary share sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary share subject to redemption to be classified outside of permanent equity.

If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value and subsequently adjusted the redemption book value as of the IPO date for the earnings in the Trust Account. The change in the carrying value of redeemable ordinary share resulted in charges against additional paid-in capital and accumulated deficit. The carrying amount of ordinary shares subject to possible redemption excludes any potential reduction for up to $100,000 of funds held in trust that the Company may use to fund liquidation expenses. The Company will reduce the carrying amount of temporary equity for the availability of these funds only in the event that the Company’s liquidation becomes probable.

13

Table of Contents

As of September 30, 2022 and December 31, 2021, the ordinary shares subject to possible redemption reflected on the consolidated balance sheets are reconciled in the following table:

Gross proceeds from IPO

    

$

265,147,800

Less:

 

  

Proceeds allocated to Public Warrants, net of offering costs

 

(14,052,833)

Ordinary share issuance costs

 

(24,729,441)

Plus:

 

  

Remeasurement adjustment of carrying value to redemption value

 

38,782,274

Ordinary shares subject to possible redemption as of December 31, 2021

265,147,800

Plus:

 

  

Remeasurement adjustment of carrying value to redemption value

 

25,233

Ordinary shares subject to possible redemption as of March 31, 2022

265,173,033

Plus:

 

  

Remeasurement adjustment of carrying value to redemption value

347,335

Ordinary shares subject to possible redemption as of June 30, 2022

265,520,368

Plus:

Remeasurement adjustment of carrying value to redemption value

 

1,173,325

Ordinary shares subject to possible redemption as of September 30, 2022

$

266,693,693

Net Income Per Share

The Company has two classes of ordinary shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. Private and public warrants to purchase 14,373,564 Class A ordinary shares at $11.50 per share were issued on August 2, 2021, and September 3, 2021. On May 24, 2022, the Sponsor exercised its option to convert the issued and outstanding loan amount of $1,200,000 under the Sponsor Convertible Note, resulting in the issuance of 800,000 private placement warrants to the Sponsor. Each private placement warrant entitles the Sponsor to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants sold concurrently with the Company’s initial public offering. The calculation of diluted income per common share does not consider the effect of the warrants issued in connection with the (i) IPO, (ii) exercise of over-allotment, or (iii) Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):

Three Months Ended

Three Months Ended

September 30, 2022

September 30, 2021

    

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net income per ordinary share

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Allocation of net income

$

1,598,937

$

399,734

$

7,288,281

$

2,932,047

Denominator:

 

 

 

 

Weighted average shares outstanding

 

26,514,780

 

6,628,695

 

16,477,155

 

6,628,695

Basic and diluted net income per ordinary share

$

0.06

$

0.06

$

0.44

$

0.44

14

Table of Contents

For the Period from March 11, 2021

Nine Months Ended

(Inception) through

September 30, 2022

September 30, 2021

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net income per ordinary share

  

 

  

 

  

 

  

Numerator:

  

 

  

 

  

 

  

Allocation of net income

$

49,787

$

12,447

$

5,539,602

$

4,673,803

Denominator:

 

 

 

 

Weighted average shares outstanding

 

26,514,780

 

6,628,695

 

7,467,479

 

6,300,368

Basic and diluted net income per ordinary share

$

0.00

$

0.00

$

0.74

$

0.74

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next 12 months.

The Company is considered to be an exempted Cayman Islands company with connection to Australia via MAC-Sub as a taxable jurisdiction. MAC-Sub is dormant and the Company is therefore presently not subject to income taxes or income tax filing requirements in the Cayman Islands, United States or Australia. As such, the Company’s tax provision was zero for the period presented.

Recent Accounting Pronouncements

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt -- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts on an Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements.

Note 3 — Initial Public Offering

Units

On August 2, 2021, the Company consummated its IPO of 25,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant

15

Table of Contents

of the Company (“Warrant”), each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $250,000,000. The warrants will become exercisable 30 days after the completion of the initial Business Combination. The warrants will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.

The underwriter had a 45-day option from the date of the Company’s IPO (August 2, 2021) to purchase up to an additional 3,750,000 Units to cover over-allotments.

On September 3, 2021, the underwriter partially exercised the over-allotment option to purchase an additional 1,514,780 Units (the “Over-Allotment Units”) generating aggregate gross proceeds of $15,147,800 and incurring $302,956 in cash underwriting fees (see Note 1) and $530,173 of deferred underwriting fees.

On September 16, 2021, the remaining amounts under the over-allotment option expired unused and 558,805 Class B ordinary shares were forfeited by the Sponsor to the Company for no consideration.

Warrants

Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price; (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions); and (z) the volume-weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equal or exceed $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations described below with respect to registration, or if a valid exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. If the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. If a registration statement is not effective for the exercised warrants, the purchaser of a Unit containing such warrant will have paid the full purchase price for the Unit solely for the Class A ordinary share underlying such Unit.

Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

in whole and not in part;

16

Table of Contents

at a price of $0.01 per warrant;
upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and
if, and only if, the last reported sales price (the “Closing Price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like and certain issuances of Class A ordinary shares and equity linked securities ) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).

Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below); and
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations, and the like) on the trading day before the Company sends the notice of redemption to the warrant holders.

The “fair market value” of the Class A ordinary shares shall mean the volume-weighted average price of the Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide the warrant holders with the final fair market value no later than one business day after the 10-day trading period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).

Note 4 — Private Placement

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 5,333,333 Private Placement Warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per warrant, or $8,000,000 in the aggregate.

Simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the private placement with the Sponsor for an aggregate of 201,971 warrants to purchase Class A Ordinary Shares for $1.50 per warrant in a private placement with each whole warrant entitling the holder thereof to purchase one Class A Ordinary Share at $11.50 per share, subject to adjustment (the “Additional Private Placement Warrants”), generating total proceeds of $302,956 (the “Private Placement Proceeds” and, together with the Option Unit Proceeds, the “Proceeds”) (see Note 1).

On September 16, 2021, the remaining amounts under the over-allotment option expired unused.

The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of such warrants) are not transferable, assignable, or salable until 30 days after the completion of the initial Business Combination. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO.

17

Table of Contents

Note 5 — Related Party Transactions

Founder Shares

In March 2021, the Company’s Sponsor paid $25,000, or approximately $0.003 per share, to cover certain of the offering and formation costs in exchange for an aggregate of 7,187,500 Class B ordinary shares, par value $0.0001 per share, of which 937,500 shares were subject to forfeiture depending on the extent to which the underwriter’s over-allotment option was exercised.

On September 3, 2021, the Underwriter partially exercised the over-allotment option to purchase an additional 1,514,780 Units. On September 16, 2021, the remaining amounts under the over-allotment option expired unused. Consequently, 558,805 shares were forfeited by the Sponsor for no consideration.

The Company’s initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Promissory Note — Related Party

The Sponsor has agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans were non-interest bearing, unsecured and due at the earlier of December 31, 2021, or the closing of the IPO. The outstanding balance under the promissory note was repaid at the closing of the IPO on August 2, 2021. No amounts were outstanding as of September 30, 2022 and December 31, 2021.

Advances from Related Parties

The Sponsor or an affiliate of the Sponsor occasionally incurs expenses on behalf of the Company. The liability is non-interest bearing and due on demand; as of September 30, 2022 and December 31, 2021, there was no amount payable. During the period from March 11, 2021 (inception) through December 31, 2021, the Company received advances from related parties of $150,000. These advances which were non-interest bearing and due on demand and were fully repaid at the close of the IPO.

Working Capital Loans

To finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company will repay the Working Capital Loans. If the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Warrants of the post Business Combination entity at a price of $1.50 per warrant, at the option of the lender. Such warrants would be identical to the Private Placement Warrants. At September 30, 2022 and December 31, 2021, there were no Working Capital Loans outstanding.

On May 6, 2022, the Company entered into a convertible promissory note agreement with the Sponsor pursuant to which the Sponsor agreed to loan the Company up to an aggregate principal amount of $1,200,000. The Sponsor Convertible Note is non-interest bearing and payable on the earlier of (i) August 2, 2023, or (ii) the date on which the Company consummates the initial Business Combination. If the Company does not consummate the Business Combination, the Company may use a portion of any funds held outside the Trust Account to repay the Sponsor Convertible Note; however, no proceeds from the Trust Account may be used for such repayment. Up to $1,200,000 of the Sponsor Convertible Note may be converted into warrants at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants; provided, however, that (i) the warrants will not be subject to forfeiture in connection with the Business Combination and (ii) the warrants will grant the holders the right to purchase one ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants.

18

Table of Contents

Concurrently with entering into the agreement, the Company borrowed $1,200,000 against the Sponsor Convertible Note. On May 24, 2022, the Sponsor exercised the conversion option and converted the issued and outstanding loan balance of $1,200,000 under the Sponsor Convertible Note into 800,000 private placement warrants. As of September 30, 2022, there were no outstanding amounts under the Sponsor Convertible Note.

The Company assessed the provisions of the Sponsor Convertible Note under ASC 470-20. The derivative component of the obligation was initially valued and classified as a derivative liability. The conversion option was valued using a Monte Carlo Simulation method, which is considered to be a Level 3 fair value measurement and based on the following assumptions (see Note 6):

May 24, 2022

May 6, 2022

Conversion

Borrowing

(Final

(Initial

    

Measurement)

    

Measurement)

Underlying warrant value

$

0.60

$

0.80

Exercise price

$

1.50

$

1.50

Holding period

0.35

0.40

Risk-free rate%

1.25

%  

1.18

%

Volatility%

59.57

%  

55.35

%

The following table presents the change in the fair value of the conversion option liability for the borrowing on May 6, 2022 for $1,200,000:

Fair value as of May 6, 2022

    

$